Streetbeat News

AEON

AEON Biopharma, Inc.

http://www.aeonbiopharma.com

Industry

Biotechnology

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Aeon Biopharma has filed with the SEC for a Class A common stock offering, aiming to raise up to $50 million.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 8:30 pm

HC Wainwright & Co. has maintained a Buy rating on AEON Biopharma but lowered the price target from $6 to $5.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 12:15 pm

AEON Biopharma (AMEX:AEON) reported Q2 2024 GAAP EPS of $4.22, significantly surpassing the estimated $(0.19) by 2321.05%.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:13 pm

Shares of The Charles Schwab Corporation (NYSE:SCHW) fell over 7% following their second-quarter results, which showed a decline in adjusted net income and EPS. Other stocks such as Yoshitsu Co., Ltd (NASDAQ:TKLF) and Silo Pharma, Inc. (NASDAQ:SILO) saw significant gains, while Cyngn Inc. (NASDAQ:CYN) and Autonomix Medical, Inc. (NASDAQ:AMIX) experienced notable declines.

Portfolio Pulse from Avi Kapoor

July 16, 2024 | 5:06 pm

Shares of Match Group (NASDAQ:MTCH) rose sharply in pre-market trading due to Starboard Value's 6.5% stake and potential advocacy for a sale. Other notable pre-market movers include Conduit Pharmaceuticals (NASDAQ:CDT), Meiwu Technology (NASDAQ:WNW), and AEON Biopharma (NYSE:AEON).

Portfolio Pulse from Avi Kapoor

July 16, 2024 | 9:51 am

SolarEdge Technologies, Inc. (NASDAQ:SEDG) shares fell 12.2% after announcing a workforce reduction of 400 employees. Other notable stock movements include Autonomix Medical, Inc. (NASDAQ:AMIX) climbing 148% and Trump Media & Technology Group Corp. (NASDAQ:DJT) rising 32.8% following an attempted assassination of Donald Trump.

Portfolio Pulse from Avi Kapoor

July 15, 2024 | 5:23 pm

HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on AEON Biopharma and maintained a $6 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 11:26 am

AEON Biopharma shares are trading higher following the company's announcement of a resource prioritization and cost reduction plan.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 2:53 pm

AEON Biopharma, Inc. (NYSE:AEON) announced a strategic reprioritization and cost reduction plan, including a 55% workforce reduction, to extend its cash runway into Q4 2024. The company is evaluating financing options for its late-stage clinical pipeline for ABP-450.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:17 pm

The article highlights the pre-market movements of various health care stocks on Thursday. Notable gainers include OneMedNet (ONMD), iSpecimen (ISPC), P3 Health Partners (PIII), Bicycle Therapeutics (BCYC), Calliditas Therapeutics (CALT), and AEON Biopharma (AEON). On the losing side, Ensysce Biosciences (ENSC), Cytokinetics (CYTK), DermTech (DMTK), SILO Pharma (SILO), Tango Therapeutics (TNGX), and Vicarious Surgical (RBOT) saw declines.

Portfolio Pulse from Benzinga Insights

May 23, 2024 | 12:06 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.